Lineage Cell Therapeutics Inc (LCTX) Stock Price, Quote & News

Company Profile

Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for neurological and ophthalmic conditions in the United States and internationally. The company develops OpRegen, an allogeneic retinal pigment epithelium cell replacement therapy, which is in Phase 2a clinical trial for the treatment of the age-related macular degeneration; OPC1, an allogeneic oligodendrocyte progenitor cell therapy that is in Phase 1/2a multicenter clinical trial for the tre...

Industry: Biotechnology

Sector: Healthcare

Phone: 442 287 8990

Website: www.lineagecell.com

Address:

2173 Salk Avenue, Suite 200, Carlsbad, United States

Raygun_24 Oct. 25 at 4:13 PM

$LCTX 👇 this POS troll doesn’t even know what they’re bearish against. Just an Incel that gets off spreading BS. What a loser. Sad really.

1 · Reply

JohnPDaly Oct. 25 at 4:04 PM

$LCTX Share Price Watching

0 · Reply

BluejayshandedLAtheirass Oct. 25 at 3:56 PM

$LCTX not nowhere nimrod if Bitcoin explodes so will ltc geeeez narrow minded knumbskull

0 · Reply

JohnPDaly Oct. 25 at 2:32 PM

$LCTX Dominos starting to fall.

0 · Reply

primordialATOM Oct. 25 at 2:29 PM

$LCTX I don't know if Genentech has Cart-T expertise or competence in its development. But having a viable multi-tissue catalogue of regenerative capable non-immuno suppressed genetic modified material they can mass produce with Swiss devised medical surgical implantation would be the EPITOME of FUTURE MEDICAL SCIENCE.....

1 · Reply

primordialATOM Oct. 25 at 2:20 PM

$LCTX I MEANT SANA not sava.....

0 · Reply

primordialATOM Oct. 25 at 2:17 PM

$LCTX Roche should talk partnership with SAVA if they find their science to be plausible and the behemouth of RESTORATIVE MEDICINE would be on its way to WORLD DOMINATION. The swiss would have the best CURES and the BEST WATCHES......

0 · Reply

JohnPDaly Oct. 25 at 1:35 PM

$LCTX $MDWD https://x.com/iancassel/status/1981867136567197838?s=12

0 · Reply

josegodoy Oct. 25 at 8:44 AM

$LCTX I believe LCTX is talks to expand their relationship (in some way). An opinion

3 · Reply

Raygun_24 Oct. 25 at 12:10 AM

$LCTX hidden gem- will explode any day out of nowhere!

1 · Reply

Lineage Cell Therapeutics, Inc. (LCTX) Presents At H.C. Wainwright 27th Annual Global Investment Conference Prepared Remarks Transcript

Sep 8, 2025, 8:00 AM EDT - 6 weeks ago

Lineage Cell Therapeutics Initiates Cell Transplant Program In Type 1 Diabetes

Sep 2, 2025, 8:00 AM EDT - 7 weeks ago

Lineage Cell Therapeutics to Present at September 2025 Investor Conferences

Aug 26, 2025, 8:00 AM EDT - 2 months ago

Lineage Announces Research Collaboration With William Demant Invest to Develop ReSonance™ (ANP1) for Hearing Loss

Aug 12, 2025, 9:16 PM EDT - 2 months ago

Lineage Cell Therapeutics, Inc. (LCTX) Q2 2025 Earnings Call Transcript

Aug 12, 2025, 4:01 PM EDT - 2 months ago

Lineage Cell Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

Aug 5, 2025, 8:00 AM EDT - 2 months ago

Lineage Cell Therapeutics to Report Second Quarter 2025 Financial Results and Provide Business Update on August 12, 2025

Aug 4, 2025, 8:00 AM EDT - 2 months ago

Lineage Announces Dosing of First Patient in New Clinical Study of OPC1 for Subacute and Chronic Spinal Cord Injury

Jun 23, 2025, 7:39 AM EDT - 4 months ago

Two Biotech Stocks Poised For Big Moves On Monday

SANA

Jun 23, 2025, 7:00 AM EDT - 4 months ago

OpRegen® (RG6501) 36-Month Visual Acuity Results Featured at Clinical Trials at the Summit 2025

Jun 5, 2025, 8:00 AM EDT - 5 months ago

Lineage Cell Therapeutics Announces Updates to the 3rd Annual Spinal Cord Injury Investor Symposium

May 14, 2025, 8:00 AM EDT - 5 months ago

Lineage to Present at 3rd Annual H.C. Wainwright BioConnect Investor Conference at Nasdaq NYC

May 13, 2025, 5:53 PM EDT - 5 months ago

Lineage Cell Therapeutics, Inc. (LCTX) Q1 2025 Earnings Call Transcript

May 13, 2025, 4:01 PM EDT - 5 months ago

Lineage Cell Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

May 12, 2025, 8:00 AM EDT - 5 months ago

RG6501 (OpRegen®) Phase 1/2a Clinical Study 36 Month Results to Be Featured at Clinical Trials at the Summit 2025

May 1, 2025, 8:00 AM EDT - 6 months ago

Lineage Cell Therapeutics to Report First Quarter 2025 Financial Results and Provide Business Update on May 13, 2025

Apr 22, 2025, 8:00 AM EDT - 6 months ago

Lineage Cell Therapeutics and the Christopher & Dana Reeve Foundation Proudly Announce the 3rd Annual Spinal Cord Injury Investor Symposium

Apr 21, 2025, 8:00 AM EDT - 6 months ago

Lineage to Present at 2025 Eyecelerator Meeting Sponsored by the American Academy of Ophthalmology (AAO)

Mar 10, 2025, 8:16 PM EDT - 8 months ago

Lineage Cell Therapeutics, Inc. (LCTX) Q4 2024 Earnings Call Transcript

Mar 10, 2025, 4:05 PM EDT - 8 months ago

Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update

Mar 5, 2025, 8:00 AM EST - 8 months ago

Lineage Cell Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on March 10, 2025

Feb 11, 2025, 8:00 AM EST - 9 months ago

Lineage Initiates Clinical Study of OPC1 for Spinal Cord Injury

Feb 4, 2025, 8:00 AM EST - 9 months ago

Lineage Cell Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Lifesciences Conference

Jan 27, 2025, 4:05 PM EST - 9 months ago

Lineage Cell Therapeutics Announces Closing of Second Tranche of Previously Announced Registered Direct Offering

Jan 6, 2025, 8:00 AM EST - 10 months ago

Lineage Cell Therapeutics Issues Letter to Stockholders

Nov 21, 2024, 5:00 PM EST - 1 year ago

Lineage Cell Therapeutics Announces First Closing of up to $66 Million Registered Direct Offering

Nov 20, 2024, 8:00 AM EST - 1 year ago

Lineage Cell Therapeutics Announces Pricing of up to $66 Million Registered Direct Offering

Nov 14, 2024, 9:39 PM EST - 1 year ago

Lineage Cell Therapeutics, Inc. (LCTX) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 4:01 PM EST - 1 year ago

Lineage Cell Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update

Nov 7, 2024, 8:00 AM EST - 1 year ago

Lineage Cell Therapeutics to Report Third Quarter 2024 Financial Results and Provide Business Update on November 14, 2024

Oct 14, 2024, 8:00 AM EDT - 1 year ago

Lineage Cell Therapeutics to Present at the Maxim Group 2024 Virtual Healthcare Summit

Sep 25, 2024, 8:00 AM EDT - 1 year ago

OpRegen® (RG6501) Phase 1/2a Results to Be Featured at International Society for Stem Cell Research (ISSCR) 2024 Copenhagen International Symposium

Sep 18, 2024, 8:00 AM EDT - 1 year ago

Lineage Presents Preclinical Data on Its Auditory Neuronal Cell Transplant Program, ReSonance™, at the 59th Annual Inner Ear Biology Workshop

Aug 13, 2024, 8:00 AM EDT - 1 year ago

Lineage Cell Therapeutics to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference

Aug 10, 2024, 12:03 AM EDT - 1 year ago

Lineage Cell Therapeutics, Inc. (LCTX) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 4:05 PM EDT - 1 year ago

Lineage Cell Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

Aug 1, 2024, 8:00 AM EDT - 1 year ago

Lineage Cell Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024

Jul 2, 2024, 8:00 AM EDT - 1 year ago

Lineage Cell Therapeutics Added to Membership of 2024 Russell 3000® Index

May 30, 2024, 8:00 AM EDT - 1 year ago

Lineage to Present at 2024 BIO International Convention

May 21, 2024, 8:00 AM EDT - 1 year ago

Lineage Announces Updates to 2nd Annual Spinal Cord Injury Investor Symposium

May 10, 2024, 12:33 AM EDT - 1 year ago

Lineage Cell Therapeutics, Inc. (LCTX) Q1 2024 Earnings Call Transcript

May 9, 2024, 4:01 PM EDT - 1 year ago

Lineage Cell Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

May 6, 2024, 8:00 AM EDT - 1 year ago

OpRegen® (RG6501) Phase 1/2a Clinical Study 24-Month Visual Acuity Results Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit

May 2, 2024, 8:00 AM EDT - 1 year ago

Lineage Cell Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024

Apr 30, 2024, 8:00 AM EDT - 1 year ago

Lineage Receives Grant From California Institute for Regenerative Medicine (CIRM)

Apr 29, 2024, 4:30 PM EDT - 1 year ago

Lineage Announces Changes to Board of Directors

Apr 23, 2024, 8:05 AM EDT - 1 year ago

Lineage Announces Appointment of New Board Member

Apr 1, 2024, 8:00 AM EDT - 1 year ago

Lineage Announces Appointment of Charlotte Hubbert, Ph.D., as Vice President of Corporate Development

Mar 18, 2024, 8:00 AM EDT - 1 year ago

Lineage Cell Therapeutics and the Christopher & Dana Reeve Foundation Proudly Announce the 2nd Annual Spinal Cord Injury Investor Symposium

Mar 13, 2024, 8:00 AM EDT - 1 year ago

RG6501 (OpRegen®) Phase 1/2a Clinical Study 24 Month Results to Be Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit

Raygun_24 Oct. 25 at 4:13 PM

$LCTX 👇 this POS troll doesn’t even know what they’re bearish against. Just an Incel that gets off spreading BS. What a loser. Sad really.

1 · Reply

JohnPDaly Oct. 25 at 4:04 PM

$LCTX Share Price Watching

0 · Reply

BluejayshandedLAtheirass Oct. 25 at 3:56 PM

$LCTX not nowhere nimrod if Bitcoin explodes so will ltc geeeez narrow minded knumbskull

0 · Reply

JohnPDaly Oct. 25 at 2:32 PM

$LCTX Dominos starting to fall.

0 · Reply

primordialATOM Oct. 25 at 2:29 PM

1 · Reply

primordialATOM Oct. 25 at 2:20 PM

$LCTX I MEANT SANA not sava.....

0 · Reply

primordialATOM Oct. 25 at 2:17 PM

0 · Reply

JohnPDaly Oct. 25 at 1:35 PM

$LCTX $MDWD https://x.com/iancassel/status/1981867136567197838?s=12

0 · Reply

josegodoy Oct. 25 at 8:44 AM

$LCTX I believe LCTX is talks to expand their relationship (in some way). An opinion

3 · Reply

Raygun_24 Oct. 25 at 12:10 AM

$LCTX hidden gem- will explode any day out of nowhere!

1 · Reply

SPS614 Oct. 24 at 11:00 PM

$LCTX One of the main reasons small biotechs like Lineage need partners: https://www.biospace.com/business/priority-review-vouchers-by-the-numbers Can you imagine the dilution that would happen if Lineage wanted to go this route and had to boot strap it? Thanks RG!

1 · Reply

Special_Elvis Oct. 24 at 9:25 PM

$LCTX

0 · Reply

Special_Elvis Oct. 24 at 8:58 PM

$LCTX Linkedin post I just came across from ~2 months ago.

1 · Reply

ChasRiggs Oct. 24 at 5:03 PM

$LCTX six seven.

3 · Reply

Tootie Oct. 24 at 4:14 PM

$LCTX “69”!

0 · Reply

MNactuary Oct. 24 at 3:12 PM

$LCTX nice movement today

1 · Reply

qwertylicious2003 Oct. 24 at 2:20 PM

$LCTX https://www.prnewswire.com/news-releases/lilly-to-acquire-adverum-biotechnologies-302593482.html

2 · Reply

DiligentInvesting Oct. 24 at 2:18 PM

$LCTX Good to be back above $1.66. Now let's get $3. (LOL)

0 · Reply

DiligentInvesting Oct. 24 at 1:40 PM

$LAES Needs contracts. And frankly, so does $LCTX.

0 · Reply

DiligentInvesting Oct. 24 at 1:00 PM

$LCTX Patience is like bread I say I ran out of that yesterday. It's about time. Let's get this BC. https://www.youtube.com/watch?v=ZOc1gNO1xWs

0 · Reply

LauraPod Oct. 24 at 11:49 AM

$LCTX Check out INBX this morning up 58% on positive trial results for a large unmet need. Every day its another biotech but one day it will be us.

2 · Reply

qwertylicious2003 Oct. 24 at 11:21 AM

$LCTX regenerative medicine is coming! https://www.healio.com/news/ophthalmology/20250918/after-years-of-research-corneal-endothelial-cell-transplantation-comes-to-fruition

0 · Reply

Market Cap	372.22M
Revenue (ttm)	9.50M
Net Income (ttm)	-18.61M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-195.89%
Debt to Equity Ratio	0.00

Volume	1,006,000
Avg Vol	1,733,906
Day's Range	N/A - N/A
Shares Out	228.36M
Stochastic %K	53%
Beta	1.77
Analysts	Strong Sell
Price Target	$4.17